Skip to main content

Peer Review reports

From: Comparison of surgery rates in biologic-naïve patients with Crohn’s disease treated with vedolizumab or ustekinumab: findings from SOJOURN

Original Submission
13 Oct 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Nov 2022 Reviewed Reviewer Report
7 Dec 2022 Reviewed Reviewer Report
2 Feb 2023 Author responded Author comments - Ninfa Candela
Resubmission - Version 3
2 Feb 2023 Submitted Manuscript version 3
7 Feb 2023 Author responded Author comments - Ninfa Candela
Resubmission - Version 4
7 Feb 2023 Submitted Manuscript version 4
13 Feb 2023 Reviewed Reviewer Report
15 Feb 2023 Reviewed Reviewer Report
2 Mar 2023 Author responded Author comments - Ninfa Candela
Resubmission - Version 5
2 Mar 2023 Submitted Manuscript version 5
10 Mar 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
14 Mar 2023 Editorially accepted
25 Mar 2023 Article published 10.1186/s12876-023-02723-5

You can find further information about peer review here.

Back to article page